Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.11M 1.97M 1.81M 3.43M 232M 3.46M 23.25M 9.09M 116M 9.15M 8.95M 384M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.82M 10.09M 9.27M 17.52M 1.19B 17.72M 119M 46.48M 592M 46.78M 45.76M 1.96B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+3.40%+14.56% - - 23.79B
-0.28%+1.74%-32.43%+0.57% 15.78B
+14.88%+21.38%-38.86%-46.14% 9.79B
+2.92%+22.05%+12.85%+110.70% 8.4B
+3.79%+13.35%-25.06%+290.87% 4.87B
+2.21%+11.56%-36.01%-15.82% 2.56B
+2.60%+8.24%-30.63%-36.04% 2.05B
-0.64%+4.56%+31.45%+93.03% 1.66B
-0.59%-3.26%+0.47%+47.04% 1.45B
Average +1.30%+8.03%-14.78%+55.53% 7.03B
Weighted average by Cap. +1.78%+11.06%-21.66%+43.20%

Financials

2018 2019 *
Net sales 3.32M 2.88M 2.69M 2.47M 4.67M 316M 4.72M 31.71M 12.39M 158M 12.47M 12.2M 523M -
Net income -15.94M -13.84M -12.9M -11.85M -22.42M -1.52B -22.67M -152M -59.47M -758M -59.86M -58.54M -2.51B -
Net Debt 10.02M 8.7M 8.11M 7.45M 14.1M 953M 14.25M 95.66M 37.39M 477M 37.64M 36.81M 1.58B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock